Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Christopher Mings

Physician Assistant Fort Pierce, FL Physician Assistant

NPI 1326452251 CMS profile 10561904

2401 Frist Blvd Ste 5, Fort Pierce, FL 34950

Open in the dashboard

General payments

$211,186

484 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Christopher Mings of Fort Pierce, FL is reported in the CMS Open Payments database as having received $211,186 across 484 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $110,589 186
2024 General $65,748 173
2023 General $26,967 76
2022 General $7,315 36
2021 General $567 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christopher Mings
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Christopher Mings were reported at $110,589. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Christopher Mings Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $567 $132 $37–$438 $132
2022 $7,315 $155 $48–$522 $149
2023 $26,967 $167 $52–$557 $160
2024 $65,748 $178 $55–$600 $164
2025 $110,589 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Atricure, Inc. $209,943 445 payments
  2. Edwards Lifesciences Corporation $270 7 payments
  3. Maquet Cardiovascular U.S. Sales, L.L.C. $262 9 payments
  4. Abiomed $243 6 payments
  5. Medtronic, Inc. $191 4 payments
  6. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $68 4 payments
  7. Boston Scientific Corporation $59 2 payments
  8. Becton, Dickinson and Company $52 2 payments
  9. AngioDynamics, Inc. $26 1 payment
  10. KLS-Martin L.P. $21 1 payment
  11. Other $50 3 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Consulting Fee $160,356 64 payments
  2. Travel and Lodging $32,593 166 payments
  3. Food and Beverage $15,672 249 payments
  4. Education $2,513 3 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $52 2 payments
Products named General payments · program years 2021–2025
  1. SYNERGY ABLATION SYSTEM $155,648 287 payments
  2. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $29,960 92 payments
  3. AtriCure cryoICE cryoSPHERE Cryoablation System $29,865 81 payments
  4. ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) $5,925 25 payments
  5. ATRICLIP LAA EXCLUSION SYSTEM $5,088 46 payments
  6. FUSION ABLATION SYSTEM $1,619 5 payments
  7. LARIAT RS $563 1 payment
  8. Impella $193 4 payments
  9. ISOLATOR SURGICAL ABLATION SYSTEM $176 1 payment
  10. VASOVIEW HEMOPRO 2 $174 5 payments
  11. Other $744 25 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

275

Median for Physician Assistant: 241

Drug cost

$1,990

Median for Physician Assistant: $4,110

Branded share of claims

13.1%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clopidogrel Clopidogrel Bisulfate Brand 36 $679
Metoprolol Tartrate Generic 36 $385
Amiodarone Hcl Generic 40 $320
Pantoprazole Sodium Generic 50 $319
Oxycodone Hcl Generic 51 $113
Colchicine Generic 13 $96
Tramadol Hcl Generic 21 $36
Potassium Chloride Generic 13 $30
Furosemide Generic 15 $12

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 37 billing codes

Paid by Medicare

$19,345

Medicare's payments for the services billed

Medicare patients

117

Average age 76

Services billed

244

34 women, 83 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 66%
Atrial fibrillation 62%
Diabetes 50%
Chronic kidney disease 50%
COPD 45%
Arthritis 42%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

484 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record